173 related articles for article (PubMed ID: 29158770)
21. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State.
Charytoniuk T; Harasim-Symbor E; Polak A; Drygalski K; Berk K; Chabowski A; Konstantynowicz-Nowicka K
Anticancer Agents Med Chem; 2019; 19(1):121-129. PubMed ID: 30585550
[TBL] [Abstract][Full Text] [Related]
22. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.
Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG
PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195
[TBL] [Abstract][Full Text] [Related]
23. The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
Sztolsztener K; Harasim-Symbor E; Chabowski A; Konstantynowicz-Nowicka K
Biochem Biophys Res Commun; 2021 Dec; 585():132-138. PubMed ID: 34801933
[TBL] [Abstract][Full Text] [Related]
24. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
Xiao Z; Chu Y; Qin W
Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
[TBL] [Abstract][Full Text] [Related]
25. Fetuin B aggravates liver X receptor-mediated hepatic steatosis through AMPK in HepG2 cells and mice.
Zhou W; Yang J; Zhu J; Wang Y; Wu Y; Xu L; Yang Y
Am J Transl Res; 2019; 11(3):1498-1509. PubMed ID: 30972177
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
[TBL] [Abstract][Full Text] [Related]
27. Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease.
Ran LS; Wu YZ; Gan YW; Wang HL; Wu LJ; Zheng CM; Ming Y; Xiong R; Li YL; Lei SH; Wang X; Lao XQ; Zhang HM; Wang L; Chen C; Zhao CY
J Nat Med; 2023 Jan; 77(1):73-86. PubMed ID: 36115008
[TBL] [Abstract][Full Text] [Related]
28. Structural determinants of plant lignans for the formation of enterolactone in vivo.
Saarinen NM; Smeds A; Mäkelä SI; Ammälä J; Hakala K; Pihlava JM; Ryhänen EL; Sjöholm R; Santti R
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):311-9. PubMed ID: 12270222
[TBL] [Abstract][Full Text] [Related]
29. A single bout of exercise increases the expression of glucose but not fatty acid transporters in skeletal muscle of IL-6 KO mice.
Lukaszuk B; Bialuk I; Górski J; Zajączkiewicz M; Winnicka MM; Chabowski A
Lipids; 2012 Aug; 47(8):763-72. PubMed ID: 22623023
[TBL] [Abstract][Full Text] [Related]
30.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
31. Effect of IL-6 deficiency on myocardial expression of fatty acid transporters and intracellular lipid deposits.
Chabowski A; Zmijewska M; Górski J; Bonen A; Kamiński K; Winnicka MM
J Physiol Pharmacol; 2007 Mar; 58(1):73-82. PubMed ID: 17440227
[TBL] [Abstract][Full Text] [Related]
32. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
[TBL] [Abstract][Full Text] [Related]
33. Hugan Qingzhi medication ameliorates hepatic steatosis by activating AMPK and PPARα pathways in L02 cells and HepG2 cells.
Yin J; Luo Y; Deng H; Qin S; Tang W; Zeng L; Zhou B
J Ethnopharmacol; 2014 May; 154(1):229-39. PubMed ID: 24735863
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D improves hepatic steatosis in NAFLD
Du T; Xiang L; Zhang J; Yang C; Zhao W; Li J; Zhou Y; Ma L
Front Endocrinol (Lausanne); 2023; 14():1138078. PubMed ID: 37033263
[TBL] [Abstract][Full Text] [Related]
35. PRDX6 Promotes Fatty Acid Oxidation
Shen W; Yang L; Yang Y; Wang P; Tao X; Shen Y; Wang S; Shen Y
Antioxid Redox Signal; 2023 Jun; 38(16-18):1184-1200. PubMed ID: 36401357
[No Abstract] [Full Text] [Related]
36. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B
Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747
[TBL] [Abstract][Full Text] [Related]
37. The Different Mechanisms of Lipid Accumulation in Hepatocytes Induced by Oleic Acid/Palmitic Acid and High-Fat Diet.
Zhang M; Bai X; Du Q; Xu J; Wang D; Chen L; Dong K; Chen Z; Yang J
Molecules; 2023 Sep; 28(18):. PubMed ID: 37764494
[TBL] [Abstract][Full Text] [Related]
38. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
39. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY
World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092
[TBL] [Abstract][Full Text] [Related]
40. Challenging of AS160/TBC1D4 Alters Intracellular Lipid milieu in L6 Myotubes Incubated With Palmitate.
Mikłosz A; Łukaszuk B; Żendzian-Piotrowska M; Brańska-Januszewska J; Ostrowska H; Chabowski A
J Cell Physiol; 2017 Sep; 232(9):2373-2386. PubMed ID: 27714805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
